
Opinion|Videos|February 20, 2025
Step Edits Associated with IV Iron Therapies
Panelists discuss how increasing insurance step edit requirements for high-dose IV iron formulations have created barriers to optimal patient care, requiring providers to implement strategic prior authorization processes and develop documentation protocols to demonstrate medical necessity while advocating for appropriate patient access to these medications.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How has the recent increase in step edits for high-dose IV iron injections impacted your practice?
- How can providers still ensure access to high-dose IV iron formulations?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
3
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
4
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
5





